Senate health committee ranking member Richard Burr (R-NC) (Shawn Thew/Pool via AP)
FDA user fee bill deadline falls apart? Thousands of pink slips for FDA could be coming as Burr seeks to start anew
The battle over what to include in this latest round of user fee legislation — the industry money that pays for all biopharma drug and biologic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
